Related references
Note: Only part of the references are listed.Cellular uptake of solid lipid nanoparticles and cytotoxicity of encapsulated paclitaxel in A549 cancer cells
Hong Yuan et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)
Photodynamic therapy of experimental B-16 melanoma in mice with tumor-targeted 5,10,15,20-tetraphenylporphin-loaded PEG-PE micelles
Igor Skidan et al.
JOURNAL OF DRUG TARGETING (2008)
Apoptotic epidermal growth factor (EGF)-Conjugated block copolymer micelles as a nanotechnology platform for targeted combination therapy
Helen Lee et al.
MOLECULAR PHARMACEUTICS (2007)
Current perspectives of solubilization: Potential for improved bioavailability
Subrata Mallick et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2007)
TAT peptide-based micelle system for potential active targeting of anti-cancer agents to acidic solid tumors
Vijay A. Sethuraman et al.
JOURNAL OF CONTROLLED RELEASE (2007)
Antinucleosome antibody-modified liposomes and lipid-core micelles for tumor-targeted delivery of therapeutic and diagnostic agents
Tamer A. Elbayoumi et al.
JOURNAL OF LIPOSOME RESEARCH (2007)
Micellar nanocarriers: Pharmaceutical perspectives
V. P. Torchilin
PHARMACEUTICAL RESEARCH (2007)
Mechanistic study of solubility enhancement of nifedipine using vitamin E TPGS or solutol HS-15
M Rajebahadur et al.
DRUG DELIVERY (2006)
Solubilization behavior of a poorly soluble drug under combined use of surfactants and cosolvents
K Kawakami et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2006)
Solubilization of poorly soluble PDT agent, meso-tetraphenylporphin, in plain or immunotargeted PEG-PE micelles results in dramatically improved cancer cell killing in vitro
A Roby et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2006)
Targeting death receptors in cancer with Apo2/TRAIL
SK Kelley et al.
CURRENT OPINION IN PHARMACOLOGY (2004)
Downregulation of Bcl-2, FLIP or IAPs (XIAP and survivin) by siRNAs sensitizes resistant melanoma cells to Apo2L/TRAIL-induced apoptosis
M Chawla-Sarkar et al.
CELL DEATH AND DIFFERENTIATION (2004)
An oncolytic adenoviral vector of smac increases antitumor activity of TRAIL against HCC in human cells and in mice
ZF Pei et al.
HEPATOLOGY (2004)
Immunomicelles: Targeted pharmaceutical carriers for poorly soluble drugs
VP Torchilin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Polyethylene glycol-diacyllipid micelles demonstrate increased acculumation in subcutaneous tumors in mice
AN Lukyanov et al.
PHARMACEUTICAL RESEARCH (2002)
Ectopic overexpression of second mitochondria-derived activator of caspases (Smac/DIABLO) or cotreatment with N-terminus of Smac/DIABLO peptide potentiates epothilone B derivative-(BMS 247550) and Apo-2L/TRAIL-induced apoptosis
F Guo et al.
BLOOD (2002)
Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation
H Gelderblom et al.
EUROPEAN JOURNAL OF CANCER (2001)
p-nitrophenylcarbonyl-PEG-PE-liposomes:: fast and simple attachment of specific ligands, including monoclonal antibodies, to distal ends of PEG chains via p-nitrophenylcarbonyl groups
VP Torchilin et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2001)
Pharmacokinetic modeling of paclitaxel encapsulation in Cremophor EL micelles
L van Zuylen et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2001)
Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand
M Jo et al.
NATURE MEDICINE (2000)
Share Paper
